| Profile | GDS5420 / 239979_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 450.83 | 65 |
| GSM1296119 | B_lesional_pre-dose | 731.22 | 74 |
| GSM1296076 | C_lesional_pre-dose | 122.83 | 46 |
| GSM1296092 | D_lesional_pre-dose | 368.28 | 63 |
| GSM1296103 | E_lesional_pre-dose | 651.81 | 72 |
| GSM1296078 | F_lesional_pre-dose | 199.88 | 54 |
| GSM1296107 | G_lesional_pre-dose | 327.22 | 60 |
| GSM1296109 | H_lesional_pre-dose | 357.74 | 61 |
| GSM1296080 | I_lesional_pre-dose | 334.54 | 61 |
| GSM1296090 | J_lesional_pre-dose | 269.01 | 58 |
| GSM1296074 | K_lesional_pre-dose | 373.33 | 64 |
| GSM1296111 | L_lesional_pre-dose | 282.08 | 58 |
| GSM1296099 | M_lesional_pre-dose | 512.61 | 68 |
| GSM1296086 | O_lesional_pre-dose | 151.09 | 49 |
| GSM1296117 | P_lesional_pre-dose | 610.65 | 71 |
| GSM1296113 | Q_lesional_pre-dose | 2160.25 | 91 |
| GSM1296096 | R_lesional_pre-dose | 183.15 | 51 |
| GSM1296105 | S_lesional_pre-dose | 344.83 | 61 |
| GSM1296098 | T_lesional_pre-dose | 1158.6 | 82 |
| GSM1296101 | U_lesional_pre-dose | 772.31 | 75 |
| GSM1296121 | V_lesional_pre-dose | 223.07 | 54 |
| GSM1296088 | W_lesional_pre-dose | 272.45 | 58 |
| GSM1296082 | X_lesional_pre-dose | 164.99 | 51 |
| GSM1296115 | Y_lesional_pre-dose | 474.13 | 67 |
| GSM1296084 | Z_lesional_pre-dose | 120.5 | 44 |
| GSM1296072 | B_lesional_day8 | 420.18 | 65 |
| GSM1296069 | L_lesional_day8 | 318.39 | 59 |
| GSM1296071 | P_lesional_day8 | 334.67 | 60 |
| GSM1296070 | Y_lesional_day8 | 376.64 | 62 |
| GSM1296073 | V_lesional_day8 | 275.65 | 58 |
| GSM1296034 | A_lesional_day15 | 272.05 | 56 |
| GSM1296041 | G_lesional_day15 | 361.49 | 62 |
| GSM1296035 | R_lesional_day15 | 322.61 | 60 |
| GSM1296038 | U_lesional_day15 | 388.61 | 63 |
| GSM1296047 | B_lesional_day15 | 408.98 | 64 |
| GSM1296039 | E_lesional_day15 | 1117.09 | 81 |
| GSM1296042 | H_lesional_day15 | 340.96 | 61 |
| GSM1296043 | L_lesional_day15 | 193.6 | 50 |
| GSM1296037 | M_lesional_day15 | 231.18 | 54 |
| GSM1296046 | P_lesional_day15 | 390.11 | 63 |
| GSM1296044 | Q_lesional_day15 | 601.24 | 71 |
| GSM1296045 | Y_lesional_day15 | 352.57 | 61 |
| GSM1296025 | C_lesional_day15 | 83.78 | 39 |
| GSM1296033 | D_lesional_day15 | 269.04 | 57 |
| GSM1296027 | I_lesional_day15 | 306.13 | 60 |
| GSM1296032 | J_lesional_day15 | 150.93 | 48 |
| GSM1296024 | K_lesional_day15 | 201.19 | 53 |
| GSM1296031 | W_lesional_day15 | 377.9 | 62 |
| GSM1296028 | X_lesional_day15 | 39.47 | 28 |
| GSM1296029 | Z_lesional_day15 | 110.31 | 43 |
| GSM1296026 | F_lesional_day15 | 180.3 | 52 |
| GSM1296030 | O_lesional_day15 | 155.89 | 50 |
| GSM1296040 | S_lesional_day15 | 363.31 | 62 |
| GSM1296036 | T_lesional_day15 | 1091.74 | 81 |
| GSM1296048 | V_lesional_day15 | 298.91 | 59 |
| GSM1296059 | A_lesional_day43 | 261.62 | 57 |
| GSM1296066 | G_lesional_day43 | 312.86 | 59 |
| GSM1296060 | R_lesional_day43 | 206.36 | 53 |
| GSM1296063 | U_lesional_day43 | 479.16 | 67 |
| GSM1296064 | E_lesional_day43 | 495.47 | 68 |
| GSM1296067 | H_lesional_day43 | 342.94 | 60 |
| GSM1296062 | M_lesional_day43 | 331.19 | 60 |
| GSM1296068 | Q_lesional_day43 | 355.02 | 61 |
| GSM1296050 | C_lesional_day43 | 84.83 | 39 |
| GSM1296057 | D_lesional_day43 | 173.94 | 50 |
| GSM1296052 | I_lesional_day43 | 237.48 | 56 |
| GSM1296054 | J_lesional_day43 | 211.37 | 53 |
| GSM1296049 | K_lesional_day43 | 211.53 | 53 |
| GSM1296055 | W_lesional_day43 | 359.75 | 62 |
| GSM1296053 | X_lesional_day43 | 66.32 | 35 |
| GSM1296058 | Z_lesional_day43 | 68.51 | 37 |
| GSM1296051 | F_lesional_day43 | 102.3 | 43 |
| GSM1296056 | O_lesional_day43 | 213.36 | 54 |
| GSM1296065 | S_lesional_day43 | 199.58 | 52 |
| GSM1296061 | T_lesional_day43 | 1370.88 | 84 |
| GSM1296095 | A_non-lesional_pre-dose | 114.08 | 44 |
| GSM1296120 | B_non-lesional_pre-dose | 323.24 | 60 |
| GSM1296077 | C_non-lesional_pre-dose | 46.25 | 31 |
| GSM1296093 | D_non-lesional_pre-dose | 168.04 | 49 |
| GSM1296104 | E_non-lesional_pre-dose | 283.8 | 58 |
| GSM1296079 | F_non-lesional_pre-dose | 51.06 | 31 |
| GSM1296108 | G_non-lesional_pre-dose | 313.09 | 59 |
| GSM1296110 | H_non-lesional_pre-dose | 251.53 | 54 |
| GSM1296081 | I_non-lesional_pre-dose | 122.02 | 46 |
| GSM1296091 | J_non-lesional_pre-dose | 60.1 | 35 |
| GSM1296075 | K_non-lesional_pre-dose | 68.29 | 36 |
| GSM1296112 | L_non-lesional_pre-dose | 100.86 | 38 |
| GSM1296100 | M_non-lesional_pre-dose | 170.98 | 49 |
| GSM1296087 | O_non-lesional_pre-dose | 59.86 | 36 |
| GSM1296118 | P_non-lesional_pre-dose | 109.65 | 40 |
| GSM1296114 | Q_non-lesional_pre-dose | 2275.94 | 91 |
| GSM1296097 | R_non-lesional_pre-dose | 54.99 | 33 |
| GSM1296106 | S_non-lesional_pre-dose | 248.68 | 55 |
| GSM1296102 | U_non-lesional_pre-dose | 812.52 | 76 |
| GSM1296122 | V_non-lesional_pre-dose | 232.04 | 54 |
| GSM1296089 | W_non-lesional_pre-dose | 183.27 | 50 |
| GSM1296083 | X_non-lesional_pre-dose | 74.64 | 37 |
| GSM1296116 | Y_non-lesional_pre-dose | 158.1 | 46 |
| GSM1296085 | Z_non-lesional_pre-dose | 38.27 | 27 |